1. Home
  2. PHR vs RAPP Comparison

PHR vs RAPP Comparison

Compare PHR & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phreesia Inc.

PHR

Phreesia Inc.

HOLD

Current Price

$16.49

Market Cap

1.2B

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$29.05

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHR
RAPP
Founded
2005
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2019
2024

Fundamental Metrics

Financial Performance
Metric
PHR
RAPP
Price
$16.49
$29.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
5
Target Price
$31.76
$47.80
AVG Volume (30 Days)
1.9M
413.8K
Earning Date
12-08-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$463,205,000.00
N/A
Revenue This Year
$15.41
N/A
Revenue Next Year
$14.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.33
N/A
52 Week Low
$15.41
$6.43
52 Week High
$32.76
$42.27

Technical Indicators

Market Signals
Indicator
PHR
RAPP
Relative Strength Index (RSI) 34.60 48.00
Support Level $16.17 $28.99
Resistance Level $17.33 $31.30
Average True Range (ATR) 0.55 1.79
MACD 0.19 -0.19
Stochastic Oscillator 40.43 20.32

Price Performance

Historical Comparison
PHR
RAPP

About PHR Phreesia Inc.

Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: